Table 2.
PWMs associated with patient survival in ER-positive breast cancer.
| ER+ Breast Cancer | ER- Breast Cancer | ||||
| PWM | TF | Correlation | q-value | Correlation | q-value |
| V$PR_02 | PR | -0.53 | 0.016 | -0.16 | 0.81 |
| V$CEBPDELTA_Q6 | C/EBPdelta | 0.49 | 0.057 | 0.16 | 0.98 |
| V$CREBP1_Q2 | CRE-BP1 | -0.43 | 0.079 | -0.44 | 0.15 |
| V$PR_01 | PR | -0.44 | 0.083 | -0.14 | 0.82 |
| V$GR_01 | GR | -0.43 | 0.086 | -0.29 | 0.47 |
| V$NFY_01 | NF-Y | -0.46 | 0.094 | -0.24 | 0.55 |
| V$DEAF1_01 | DEAF1 | -0.44 | 0.096 | -0.06 | 0.91 |
For each PWM, the Spearman correlation coefficients between PWM activity and patient survival in both ER-positive (ER+) and ER-negative (ER-) breast cancer are shown.